Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 0.6179 |
| Open | 0.6180 |
| Bid | 0.5074 x 100 |
| Ask | 0.6038 x 400 |
| Day's Range | 0.5660 - 0.6299 |
| 52 Week Range | 0.2900 - 1.6700 |
| Volume | |
| Avg. Volume | 1,964,690 |
| Market Cap | 123.51M |
| Beta (5Y Monthly) | 1.40 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.8800 |
| Earnings Date | Aug 06, 2024 - Aug 12, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.50 |
Simply Wall St.US$3.50 - That's What Analysts Think Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Is Worth After These Results
The analysts might have been a bit too bullish on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ), given that the company...
Insider MonkeySangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript
Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Q1 2024 Earnings Call Transcript May 9, 2024 Sangamo Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the Sangamo Therapeutics First Quarter 2024 Teleconference Call. At this time, all […]
Simply Wall St.Sangamo Therapeutics First Quarter 2024 Earnings: US$0.27 loss per share (vs US$0.13 profit in 1Q 2023)
Sangamo Therapeutics ( NASDAQ:SGMO ) First Quarter 2024 Results Key Financial Results Revenue: US$481.0k (down 100...
© 2024 Yahoo. All rights reserved.